---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156050"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:55:23.555093+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Amylyx shareholders elect Cohen, Quimi as directors; ratify Deloitte

## Summary
- Joshua Cohen and Daphne Quimi elected as Class III directors with ~32.6M and ~32.5M votes for, respectively.
- Deloitte & Touche LLP ratified as independent auditor for FY2024 with 52,023,591 votes for, 162,947 against.
- Non-binding advisory vote on NEO compensation approved: 41,211,831 for, 2,708,178 against, 38,594 abstain.
- Shareholders chose 'One Year' as preferred frequency for future say-on-pay votes (38,275,989 for one year).
- Broker non-votes of 8,341,537 on director elections and executive compensation proposals.

## SEC filing metadata
- accession: 0001193125-24-156050
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312524156050/0001193125-24-156050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312524156050/d844544d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156050
- JSON: https://secwatch.observer/filing/0001193125-24-156050.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156050.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.